Heart-attack patients likelier to survive if the doctor’s away

A study published in the Journal of the American Heart Association has found that those who had a heart attack when their cardiologists were away at big cardiology conferences fared better.

According to the study by doctors at Harvard Medical School, those who had heart attacks when interventional cardiologists were away at academic conferences were more likely to survive in the month after the event than those who had the attacks on non-conference days.

Dr Anupama Jena, lead author of the study was quoted saying: “Many medical interventions deliver no mortality benefit, and the fact that mortality actually falls for heart attack patients during these conference dates raises important questions about how care might differ during these periods.”

The researchers found that patients did better for acute cardiovascular conditions such as cardiac arrest and heart failure on the dates of the American Heart Association and the American College of Cardiology meetings. The comparison was with patients suffering similar conditions on non-conference dates within five weeks either side of the conferences.

Although there was no difference in mortality for patients with heart attacks, stenting rates in such cases decreased by a third during the dates when interventional cardiologists were attending conferences. The study has raised questions over the use of stents if a patient is stable, while acknowledging that in cases where the heart attack was caused by a blocked artery the priority is to get it unblocked at the earliest.

While some cardiologists have attributed this finding to chance, the researchers argued that interventional cardiologists who attended conferences tended to use intensive interventions for patients, which probably did more harm than good, instead of taking a more holistic approach or opting to manage the treatment with medications. Interestingly, in the study, the greatest increase in survival rates was among patients who were seen by an interventional cardiologist but did not receive a stent.

The research raises the question of what the doctors who stay behind during these conferences do differently to achieve superior results and how the ones who attend conference could learn from them.

The findings of this study buttress others in the past that have suggested that a substantial number of cardiac procedures may not just be unnecessary but actually be harmful to patients.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

    Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

    Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

    Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

    India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

    India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

    Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

    Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

    Top 30 pharma companies post 12% revenue growth in first nine months

    Top 30 pharma companies post 12% revenue growth in first nine months

    India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

    India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory